Oligomerix Names Cara Cassino Interim CEO as Alzheimer’s Drug Advances

Oligomerix has appointed biopharmaceutical industry veteran Dr. Cara Cassino as interim president and chief executive officer, bringing an experienced drug... Read More

The post Oligomerix Names Cara Cassino Interim CEO as Alzheimer’s Drug Advances appeared first on citybiz.